Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 224 $0.00 Strike: $67.81 $0.00
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · derivative · entry 6

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 224 shares

Expires 2023-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 23,011 $130.00 $2,991,430.00
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · nonDerivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,995

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $130.00 to $130.025. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 8,977 $63.10 $566,448.70
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · nonDerivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 13,810 $67.81 $936,456.10
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 224 $67.81 $15,189.44
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 09, 2020 Filed Dec 31, 2020 01:02 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 425 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-021724 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares held by Jean-Jacques Bienaime Family Trust

Disclosed balance after: 247,533

F1 · date: On July 9, 2020 the reporting person gifted 425 shares to a charitable organization.

Read SEC document
June 29, 2020 Filed Jul 1, 2020 01:48 UTC
Mueller BrianEVP, Chief Financial Officer
GrantStock Option (Right to buy Common Stock) · Derivative 13,230 $0.00 Strike: $122.18 $0.00
Disclosure

SEC source: 0001567619-20-012731 · doc1.xml · derivative · entry 3

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,230

Underlying: Common Stock · 13,230 shares

Expires 2030-06-28

F3 · date: Option grant vests 12/48th on June 29, 2021 and 1/48th on the 29th day of each month thereafter.

Read SEC document
June 29, 2020 Filed Jul 1, 2020 01:48 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 4,640 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-012731 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,744

F2 · price: Restricted stock units granted on June 29, 2020. Price not applicable.

Read SEC document
June 26, 2020 Filed Jun 30, 2020 18:11 UTC SaleCommon Stock 4,430 $123.61 $547,592.30
Disclosure

SEC source: 0001567619-20-012684 · doc1.xml · nonDerivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2020.

Read SEC document
June 19, 2020 Filed Jun 23, 2020 23:24 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001567619-20-012520 · doc1.xml · derivative · entry 4

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,700

Underlying: Common Stock · 15,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 19, 2020 Filed Jun 23, 2020 23:24 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 15,000 $124.00 $1,860,000.00
Disclosure

SEC source: 0001567619-20-012520 · doc1.xml · nonDerivative · entry 3

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,402

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.

Read SEC document
June 19, 2020 Filed Jun 23, 2020 23:24 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 15,000 $63.10 $946,500.00
Disclosure

SEC source: 0001567619-20-012520 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 22:04 UTC SaleCommon Stock 4,430 $107.46 $476,047.80
Disclosure

SEC source: 0001567619-20-011919 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,850

F1 · date: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020.

Read SEC document
May 27, 2020 Filed May 29, 2020 22:32 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011373 · doc1.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,940

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 22:48 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011375 · doc1.xml · nonDerivative · entry 1

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,915

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 22:07 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011364 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,340

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 21:38 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011362 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,280

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 21:08 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011360 · doc1.xml · nonDerivative · entry 1

HOMBACH ROBERT J. · CIK 0001496182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,210

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 20:50 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011358 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,968

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 20:23 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011343 · doc1.xml · nonDerivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,720

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 20:35 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011356 · doc1.xml · nonDerivative · entry 1

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,840

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 27, 2020 Filed May 29, 2020 20:12 UTC GrantCommon Stock 4,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011340 · doc1.xml · nonDerivative · entry 1

ANDERSON ELIZABETH M · CIK 0001758247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,790

F1 · price: Restricted stock units granted on May 27, 2020. Price not applicable.

Read SEC document
May 08, 2020 Filed May 12, 2020 17:51 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 20,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-009578 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 08, 2020 Filed May 12, 2020 17:51 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 20,000 $91.72 $1,834,400.00
Disclosure

SEC source: 0001567619-20-009578 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

Read SEC document
May 08, 2020 Filed May 12, 2020 17:51 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 20,000 $21.51 $430,200.00
Disclosure

SEC source: 0001567619-20-009578 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

Read SEC document
May 04, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 5,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 04, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $88.00 $440,000.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,552

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

Read SEC document
May 04, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $21.51 $107,550.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

Read SEC document
May 04, 2020 Filed May 7, 2020 00:10 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantStock Option (Right to buy Common Stock) · Derivative 64,150 $0.00 Strike: $90.36 $0.00
Disclosure

SEC source: 0001567619-20-009172 · doc1.xml · derivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,150

Underlying: Common Stock · 64,150 shares

Expires 2030-05-03

F2 · date: Option grant vests 12/48th on May 4, 2021 and 1/48th on the 4th day of each month thereafter.

Read SEC document
May 04, 2020 Filed May 7, 2020 00:10 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 35,040 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-009172 · doc1.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,040

F1 · price: Restricted stock units granted on May 4, 2020. Price not applicable.

Read SEC document
May 01, 2020 Filed May 5, 2020 01:45 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 12,504 $89.38 $1,117,607.52
Disclosure

SEC source: 0001567619-20-008957 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,677

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 27, 2020.

Read SEC document
May 01, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 4,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 01, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $89.38 $357,520.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,552

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

Read SEC document
May 01, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $21.51 $86,040.00
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

Read SEC document
April 30, 2020 Filed May 5, 2020 01:45 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 339 $62.59 $21,216.65
Disclosure

SEC source: 0001567619-20-008957 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,181

F1 · date: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2020 Filed May 5, 2020 23:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 339 $62.59 $21,216.65
Disclosure

SEC source: 0001567619-20-009086 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,552

F1 · date: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2020 Filed Jun 23, 2020 23:24 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 338 $62.59 $21,154.07
Disclosure

SEC source: 0001567619-20-012520 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,402

F1 · date: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2020 Filed Jul 1, 2020 01:48 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 323 $62.59 $20,215.28
Disclosure

SEC source: 0001567619-20-012731 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,104

F1 · date: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 339 $62.59 $21,216.65
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,995

F1 · date: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 20,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 20,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 20,000 $97.58 $1,951,600.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,213

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 20,000 $21.51 $430,200.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 20,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,000

Underlying: Common Stock · 20,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 20,000 $97.73 $1,954,600.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,213

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F2 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F3 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 30 shares, with the reporting person's purchase of shares at a price of $94.39 on March 3, 2020. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 23:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 20,000 $21.51 $430,200.00
Disclosure

SEC source: 0001567619-20-008620 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

Read SEC document
April 24, 2020 Filed Apr 28, 2020 18:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 2,680 $97.32 $260,813.31
Disclosure

SEC source: 0001567619-20-008539 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,656

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F4 · price: The price in column 4 is the weighted average price. The price actually received ranged from $97.17 to $97.50. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 24, 2020 Filed Apr 28, 2020 18:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 3,678 $96.85 $356,211.36
Disclosure

SEC source: 0001567619-20-008539 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,336

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $96.17 to $97.15. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 24, 2020 Filed Apr 28, 2020 18:37 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 13,642 $95.34 $1,300,592.81
Disclosure

SEC source: 0001567619-20-008539 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,014

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $95.015 to $95.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 20, 2020 Filed Apr 22, 2020 21:15 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 17,213 $90.00 $1,549,170.00
Disclosure

SEC source: 0001567619-20-008272 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,656

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
April 09, 2020 Filed Apr 13, 2020 22:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001567619-20-007886 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,000

Underlying: Common Stock · 10,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.